Home
Contact Us
Locations
916-454-6600
Clinical Trials
Radiological Associates of Sacramento (RAS), a full member of the Radiation Therapy Oncology Group. (RTOG) is a National Cancer Institute-sponsored cooperative research group that develops state-of-the-art Phase II and III clinical trials for adult cancer patients.
Our physicians are active participants in the development and completion of RTOG clinical research, and rank among the top 10 institutions nationwide in patient accrual and data quality. We also participate regularly in national clinical trials sponsored by the Southwest Oncology Group (SWOG), the National Surgical Adjuvant Breast and Bowel Project (NSABP) and the Pediatric Oncology Group (POG).
Patients referred to RAS who decide to participate in clinical trials have access to therapy devised by leading physicians in the field of cancer research and have access to new drugs and interventions before they become widely available.
Clinical trials in which ROC is actively participating
- RTOG 0937 Phase II Study Comparing Prophylactic Cranial Irradiation to Prophylactic Cranial Irradiation & Consolidative Extra-Cranial Irradiation for Small Cell Lung Cancer
- RTOG 0413/NSABP B-39 Partial Breast Protocol
- NSABP B-43 Comparison Tratuzumab Given Concurrently with RT and RT Alone for Women with HER2 Positive DCIS Resected by Lumpectomy
- RTOG 0436 Esophageal patients not treated with surgery
- RTOG 0848 Phase III Evaluating Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with resected Head of Pancreas Adenocarcinoma
- RTOG 0815 Prostate Dose escalation with or without SAD for Intermediate Risk
- RTOG 0232 - Prostate Study comparing Implant Vs External Beam Radiation plus Implant
- RTOG 0534 Short Term AD w/pelvic lymph node or prostate bed RT in post-op radical prostatectomy
- RTOG 0621 Post-Prostatectomy evaluate RT + TAS and 6 cycles Taxotere
- RTOG 0622 Trial Sm153 followed by salvage RT in high risk non-met post radical prostatectomy
- RTOG 0831 Phase III randomized Double-Blind, Placebo Controlled Evaluate Effectiveness of Tadalafil in Prevention of ED in patients Treated with RT for Prostate Cancer
(view press release) - NCT01288534 Hypofractionated Stereotactic Body Radiation Therapy (SBRT) using Continuous Real-Time Evaluation of Prostate Motion
- RTOG 0724 Concurrent Chemo & Pelvic RT with or without Adjuvant chemo in High-Risk Early Stage Cervical Cancer post Radical Hysterectomy
- RTOG 0249 Phase III Trial of Pelvic Radiation Therapy vs Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High Risk Stage Endometrial Carcinoma
- RTOG 0617 Phase III Standard Dose RT vs High Dose w/Concurrent & Consolidated Carboplatin/Pactaxel +/- Cetuximab Stage IIIa/IIIB NSCLC
- RTOG 0813 Stereotactic Lung RT Early Stage Centrally Located NSCLC in Medically Inoperable Pts T1-2, NO,NO
- ACRIN 6678 Validating PET Pre and Post Treatment Stage IIIB/IV NSCLC Scheduled to Undergo Palliative Chemotherapy
- RTOG 0839 Randomized Phase II of Pre-Op Chemoradiotherapy +/- Panitumumab Followed By Consolidation Chemotherapy In Potentially Operable Locally Advanced Non-Small Cell Lung Cancer
- RTOG 0937 Phase II Study Comparing Prophylactic Cranial Irradiation to Prophylactic Cranial Irradiation & Consolidative Extra-Cranial Irradiation Small Cell Lung Cancer
- RTOG 0937 Phase II Study Comparing Prophylactic Cranial Irradiation to Prophylactic Cranial Irradiation & Consolidative Extra-Cranial Irradiation Small Cell Lung Cancer
- RTOG 0517 Evaluating Zomata, Vit D and Calcium +/- Sr89 or SM153 in pts with bone mets from lung, breast or prostate